Loading clinical trials...
Loading clinical trials...
Phase I/II Intrathecal Gene Delivery Clinical Trial of scAAV9.P546.SLC6A1 for SLC6A1 Neurodevelopmental Disorder
Conditions
Interventions
AAV9.SLC6A1 Gene Therapy
Locations
1
United States
Nationwide Children's Hospital
Columbus, Ohio, United States
Start Date
August 25, 2025
Primary Completion Date
August 25, 2028
Completion Date
August 25, 2030
Last Updated
September 15, 2025
Lead Sponsor
Emily de los Reyes
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions